Davis & Geck

Davis & Geck was an American medical-device and surgical-products company founded in 1909 by Charles T. Davis and Fred A. Geck. The business began in Brooklyn, New York, and developed a broad portfolio of products used in wound closure, surgical technique, and aseptic practice. Although the company became particularly associated with sutures, its catalogue eventually comprised more than 2,000 product codes across multiple surgical categories. A significant early development came in 1913, when Davis & Geck introduced the Calustro-thermal process. The method heat-sterilized suture tubes after the sutures had been sealed inside them, giving hospitals a more dependable sterile product and reducing preparation time in the operating room. This reflected the company's broader focus on making surgical materials safer, more standardized, and easier for hospitals to use. American Cyanamid acquired Davis & Geck in 1930. Under American Cyanamid, the subsidiary expanded its facilities and later relocated its offices, laboratory, and production operations to Danbury, Connecticut, during the 1950s. The company also established a manufacturing plant in Manati, Puerto Rico. Its position within a larger chemical and healthcare group provided resources for research, manufacturing, and distribution while preserving Davis & Geck as a recognizable surgical-products identity. The company's most important technical contribution was the development and commercialization of synthetic absorbable sutures. Carl A. Powers and Gilbert B. Ayres patented the relevant technology in 1954, and Davis & Geck introduced the Dexon brand during the 1970s. Dexon was made from polyglycolic acid, a synthetic organic material. Synthetic absorbable sutures offered an alternative to animal-derived catgut, whose strength could vary and which could produce substantial tissue irritation. The product therefore helped broaden the use of predictable, absorbable wound-closure materials in surgery. Davis & Geck also had an influence beyond physical devices through its film library. The Davis & Geck Film Library pioneered the recording and distribution of surgical procedures for professional education. Its films and later videos were made available to surgeons and nurses as teaching resources, supporting the spread of operative knowledge and technique. The independent Davis & Geck business changed ownership several times in the late twentieth century. In 1994, American Cyanamid announced an agreement to sell its Davis & Geck surgical-products business to B. Braun Melsungen of Germany, its European joint-venture partner. The terms were not publicly disclosed in the cited reference. The product line subsequently passed to Sherwood and then to Tyco, where it was renamed Syneture. Later, the business became part of Covidien. Medtronic's acquisition of Covidien combined the two companies under Medtronic plc, placing the historical Davis & Geck operations within Medtronic's broader medical-technology portfolio. The Davis & Geck name is therefore principally historical rather than an independently operating contemporary brand.

Davis & Geck was established in 1909 in Brooklyn, New York, by Charles T. Davis and Fred A. Geck. It developed surgical and medical products, with an emphasis on sutures, wound closure, surgical technique, and aseptic practice. The company grew from a specialist manufacturer into a substantial surgical-products business whose catalogue eventually included more than 2,000 product codes. Its first widely noted technical milestone was the Calustro-thermal process, introduced in 1913. This process allowed suture tubes to be heat-sterilized after the suture material had been enclosed and sealed. The approach gave hospitals a more reliable sterile product and reduced the amount of preparation required before surgery. It also reflected the expanding importance of industrial sterilization and standardized packaging in modern operating practice. American Cyanamid acquired Davis & Geck in 1930. The acquisition placed the company inside a larger industrial and healthcare group while allowing it to continue operating under its established name. During the 1950s, Davis & Geck moved its offices, laboratory, and production facility to Danbury, Connecticut. It later opened a manufacturing plant in Manati, Puerto Rico, extending its production footprint beyond the mainland United States. Davis & Geck's major surgical innovation was its work on synthetic absorbable sutures. Carl A. Powers and Gilbert B. Ayres patented the underlying technology in 1954. During the 1970s, Davis & Geck introduced Dexon, a suture brand made from polyglycolic acid. Because the material was synthetic and absorbable, it provided a more consistent alternative to catgut, which was animal-derived and could have variable strength characteristics or cause considerable tissue irritation. Dexon helped establish synthetic absorbable sutures as an important category in wound closure. The company also contributed to medical education. Its Davis & Geck Film Library recorded surgical procedures and distributed films and videos to surgeons and nurses. The library was an early organized effort to use motion pictures and recorded demonstrations to support professional surgical training, allowing techniques to be studied beyond the operating room in which they were performed. The business underwent a series of ownership changes. In 1994, American Cyanamid announced the sale of its Davis & Geck surgical-products business to B. Braun Melsungen, a German medical-products company and American Cyanamid's European joint-venture partner. The cited source does not provide the financial terms. The product line later moved to Sherwood and then to Tyco, under which it was renamed Syneture. It subsequently became part of Covidien. Medtronic completed its acquisition of Covidien, combining the companies under Medtronic plc. As a result, Davis & Geck is best understood today as a historic surgical-products brand and business whose technologies and product heritage passed through successive corporate owners rather than as a standalone operating company.

• 1994

  Surgical-products business sold to B. Braun

  [1]Davis & Gecken.wikipedia.org

  American Cyanamid announces the sale of the Davis & Geck surgical-products business to B. Braun Melsungen.

• 1970

  Dexon sutures introduced

  [1]Davis & Gecken.wikipedia.org

  Davis & Geck introduces its Dexon polyglycolic-acid synthetic absorbable suture during the 1970s.

• 1954

  Synthetic absorbable suture technology is patented

  [1]Davis & Gecken.wikipedia.org

  Carl A. Powers and Gilbert B. Ayres patent technology associated with the later Dexon synthetic absorbable suture.

• 1950

  Operations move to Danbury

  [1]Davis & Gecken.wikipedia.org

  During the 1950s, the company's offices, laboratory, and production facility are moved to Danbury, Connecticut.

• 1930

  Acquisition by American Cyanamid

  [1]Davis & Gecken.wikipedia.org

  Davis & Geck becomes a subsidiary of American Cyanamid.

• 1913

  Calustro-thermal sterilization process introduced

  [1]Davis & Gecken.wikipedia.org

  The company introduces a heat-sterilization method for sealed suture tubes, improving sterility reliability and operating-room efficiency.

• 1909

  Davis & Geck is founded

  [1]Davis & Gecken.wikipedia.org

  Charles T. Davis and Fred A. Geck establish the surgical-products company in Brooklyn, New York.

Historically positioned as a surgical-technology company emphasizing reliable sterile products, wound closure, synthetic suture innovation, and professional surgical education.

• Synthetic absorbable suture · 1970

  Dexon

  Dexon was Davis & Geck's best-known suture brand and one of the company's most consequential contributions to surgery. Introduced during the 1970s, it used polyglycolic acid, a synthetic absorbable material. Its development gave surgeons an alternative to catgut, an animal-derived material whose strength could vary and which could produce tissue irritation. Dexon represented the broader shift toward more predictable synthetic wound-closure materials.

• Wound closure

  Surgical sutures

  Sutures formed the core of Davis & Geck's business. The company produced a wide range of materials and formats for wound closure and surgical use, supported by packaging and sterilization methods intended to deliver dependable products to hospitals. Its catalogue expanded to more than 2,000 product codes across its broader surgical portfolio.

• Sterile surgical packaging · 1913

  Calustro-thermal suture tubes

  Introduced in 1913, the Calustro-thermal process enabled suture tubes to be heat-sterilized after the sutures had been sealed inside. The innovation addressed the need for reliable sterile storage and reduced preparation work for hospitals and operating rooms.

• Surgical education

  Davis & Geck Film Library

  The Davis & Geck Film Library recorded surgical procedures and supplied films and videos to surgeons and nurses. It helped pioneer the use of recorded operations as a professional education resource, extending the company's role from manufacturing surgical products to supporting the communication of operative knowledge.

• 1994

  Sale of the surgical-products business to B. BraunM&A

  Background

  American Cyanamid announced a restructuring transaction involving its Davis & Geck surgical-products business.

  Action taken

  The surgical-products business was sold to B. Braun Melsungen, American Cyanamid's European joint-venture partner.

  Aftermath

  The product line later passed to Sherwood, then Tyco, where it was renamed Syneture, before becoming part of Covidien and subsequently Medtronic.

  Source

• 1930

  American Cyanamid acquisitionM&A

  Background

  Davis & Geck had developed into a specialist surgical-products manufacturer with a broad suture and wound-closure portfolio.

  Action taken

  American Cyanamid acquired the company and operated it as a subsidiary.

  Aftermath

  The business later expanded its facilities and moved its principal operations to Danbury, Connecticut.

  Source

• Transition of the product line into successor corporate brandsStrategy

  Background

  Following successive ownership changes, the Davis & Geck surgical-products business was incorporated into larger medical-device organizations.

  Action taken

  Tyco renamed the product line Syneture, after which the business became part of Covidien and then Medtronic.

  Aftermath

  Davis & Geck ceased to function as an independent contemporary operating brand, while its product and technology heritage continued within successor organizations.

  Source

1. 1Davis & Gecken.wikipedia.org
2. 2Davis & Geck Company Recordsarchivessearch.lib.uconn.edu